Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, @satvicked explains why price isn’t the only barrier: https://t.co/vBrehac9eG https://t.co/KHwXvmiTVV ...

Drugmakers were expecting big things when generic Ozempic hit Indian pharmacies. It didn’t happen https://t.co/FPs6SPtUwR ...

A newly published letter sent from health and human services secretary Robert F. Kennedy to the prime minister of Samoa before his ill-fated trip to the nation in 2019 shows he did intend to meddle in the country's use of the measles, mumps and rubella vaccine, despite telling Congress during congressional hearings last year the visit had “nothing to do with vaccines."Read more: https://t.co/EFoTbi15TF📸: Win McNamee via Getty Images ...

Denmark raised its 2026 economic growth forecast for the fourth time, driven mainly a bigger-than-expected boost from Novo’s new weight-loss pill https://t.co/9pCem2tm5N ...

The stock has tumbled 70% since its June 2024 peak, as the drugmaker has contended with intensifying competition from rival Eli Lilly as well as knockoff versions of its blockbuster Ozempic diabetes and Wegovy weight-loss jabs. https://t.co/A5RFiWrpA0 ...